Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,489 | -16,586 | -13,632 | -9,383 | -4,724 |
| Depreciation Amortization | 2 | 71 | 56 | 26 | 2 |
| Accounts receivable | N/A | 401 | 398 | 399 | 150 |
| Other Working Capital | 1,040 | -1,287 | -125 | -770 | -1,210 |
| Other Operating Activity | 364 | 1,452 | 603 | 370 | 380 |
| Operating Cash Flow | $-3,083 | $-15,949 | $-12,700 | $-9,358 | $-5,402 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 15,114 | 15,114 | 9,964 | 9,459 |
| PPE Investments | N/A | -28 | -28 | -28 | -28 |
| Investing Cash Flow | $N/A | $15,086 | $15,086 | $9,936 | $9,431 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 340 | 852 | 647 | 294 | 220 |
| Other Financing Activity | -159 | -253 | -253 | -253 | -243 |
| Financing Cash Flow | $181 | $599 | $394 | $41 | $-23 |
| Exchange Rate Effect | 6 | 11 | 9 | 7 | 2 |
| Beginning Cash Position | 15,956 | 16,209 | 16,209 | 16,209 | 16,209 |
| End Cash Position | 13,060 | 15,956 | 18,998 | 16,835 | 20,217 |
| Net Cash Flow | $-2,896 | $-253 | $2,789 | $626 | $4,008 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,083 | -15,949 | -12,700 | -9,358 | -5,402 |
| Capital Expenditure | N/A | -28 | -28 | -28 | -28 |
| Free Cash Flow | -3,083 | -15,977 | -12,728 | -9,386 | -5,430 |